Cresset Asset Management’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,919
| Closed | -$354K | – | 1932 |
|
|
2024
Q3 | $354K | Buy |
12,919
+467
| +4% | +$12.8K | ﹤0.01% | 1690 |
|
|
2024
Q2 | $305K | Buy |
12,452
+459
| +4% | +$11.2K | ﹤0.01% | 1674 |
|
|
2024
Q1 | $256K | Sell |
11,993
-1,462
| -11% | -$31.2K | ﹤0.01% | 1639 |
|
|
2023
Q4 | $258K | Buy |
13,455
+512
| +4% | +$9.8K | ﹤0.01% | 1540 |
|
|
2023
Q3 | $208K | Buy |
12,943
+2,095
| +19% | +$33.6K | ﹤0.01% | 1569 |
|
|
2023
Q2 | $251K | Buy |
+10,848
| New | +$251K | ﹤0.01% | 1478 |
|
|
2021
Q4 | – | Sell |
-7,081
| Closed | -$228K | – | 1234 |
|
|
2021
Q3 | $228K | Buy |
+7,081
| New | +$228K | ﹤0.01% | 973 |
|
|
2019
Q2 | – | Sell |
-121
| Closed | -$4K | – | 1235 |
|
|
2019
Q1 | $4K | Hold |
121
| – | – | ﹤0.01% | 1429 |
|
|
2018
Q4 | $4K | Buy |
+121
| New | +$4K | ﹤0.01% | 1107 |
|